The Patient Recruitment and Retention Services Market Size is valued at USD 4.1 Billion in 2024 and is predicted to reach USD 6.7 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034.
Patient recruitment and retention is an essential service for the clinical research industry, and certain developments are expected to play a significant role in the future. Patient recruitment is one of the rate-limiting stages in bringing medications to market. In addition, given the typical clinical research dropout rate, keeping patients on board is challenging. Utilizing contract service providers has been shown to hasten the patient recruiting process. In order to effectively conduct clinical research, these service providers employ a variety of outreach strategies, such as social media, mobile technologies, electronic health records (EHRs), and real-world evidence (RWE).
Retention service providers make use of different strategies such as in-house call center to address patient concerns, educational materials to keep sites engaged and study branding to encourage compliance and patient responses, creation of online and in-person support groups, electronic data capture systems, video conferencing platforms, and telemedicine tools to reduce the need for in-person visits and improve participant convenience among others
Over time, they have become increasingly significant in this process. Clinical research is conducted to learn more about the effectiveness and safety of creating new medications and medical equipment. As more people are needed for clinical trials because of regulatory and safety concerns, which are pushing trends toward longer and larger studies, the demand for patient recruiting services is increasing. The global industry has grown significantly as a result of the increasing number of clinical studies and the expanding pharmaceutical and medical industries.
With the increased complexity of clinical trials and the need for specialized patient populations for studies evaluating orphan medications and tailored therapies, several big pharma companies have outsourced their patient recruiting operations, leading to increased clinical trial costs. Delays in product release brought on by sponsors' inability to draw in and keep patients are relatively common and are considered to result in an average loss. The short suspension due to Covid-19 has significantly impacted clinical studies, especially in the area of patient recruiting.
The Patient Recruitment and Retention Services Market is segmented on the Type, Phases, Disease, Patient Age Group, and End-User. Based on Type, the market is segmented into Patient Recruitment (Recruitment Services, Patient Retention Services, and Others. Based on Disease, the market is segmented into Oncology, Infectious Disease, Endocrine/Metabolic, CNS/Neurology, Cardiovascular Disease, Hematological Disorders, and Others. Based on Trial Phases, the market is segmented into Phase I, Phase II, Phase III, and Phase IV. Patient Age group segment is divided into Pediatric, Adult, and Geriatrics. Whereas End-user segments consists of Hospitals, CROs, Pharma and Biotech Companies, Others.
The market for patient recruiting services linked to oncology is predicted to grow at a rapid pace over the forecast period. The upsurge in incidence and prevalence of various cancer disorders, the popularity of advanced therapies (such as biological and targeted pharmacological therapies), and the rising global elderly population are the main factors driving the growth of the oncology/cancer pharmaceuticals market. Additionally, the market for oncology medications is growing due to increased cancer awareness and early cancer detection. During the foreseeable period, profitable opportunities should be available due to the great potential of rising economies and the increased number of potential medications in development. The rate of advancement in cancer treatment is quickening. Emerging from the research and development pipeline are a number of novel therapies that are frequently combined with other brand-new or current medications. Numerous pharmaceutical companies are funding these revolutionary medication development projects for the treatment of cancer.
The phase III category will lead the market in the forecast period with a major revenue share due to the high cost of phase III research. Complicated clinical trials need both clinical resources and potent technology for effective patient recruitment, timely deployment of trial locations, and high-quality study management. The vast majority of pharmaceutical, biopharmaceutical, and medical device companies worldwide use clinical trial service providers to conduct Phase III clinical trials. The market will expand as a result of the several medicines and vaccines that are currently in Phase III and are indicated for the treatment of COVID-19.
North America had the greatest revenue share in the worldwide market. This market is projected to grow given the numerous clinical research being conducted in the region. Government support for clinical trials and significant R&D expenditures are fostering the market's growth. The presence of significant CROs offering support services like patient recruitment and multinational pharmaceutical and biopharmaceutical companies making sizable investments in clinical research have both been credited with the growth of the North American clinical trial patient recruitment services market. The region has become a hub for conducting clinical trials due to the low cost of research, straightforward regulatory compliance, rising patient population, and availability of a few elite clinical institutions functioning as sites.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 4.1 Bn |
|
Revenue Forecast In 2034 |
USD 6.7 Bn |
|
Growth Rate CAGR |
CAGR of 5.3 % from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, By Phases, By Disease, By Patient Age Group, By End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Acurian, BBK Worldwide, Bright Pharmaceutical Services, ClinEdge, CSSi, CTM, Evolution Research Group (ERG), Integrated Clinical Trial Services (ICTS), MMG, Veristat, WCCT Global, Antidote, Clinical Accelerator, Fidelis Research, Ignite Data, Polaris BioPharma Consulting, Raremark, Clinrol, CROee, Gitzo Medical Technology, Pacific Grove, and TrialWire. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Patient Recruitment and Retention Services Market Snapshot
Chapter 4. Global Patient Recruitment and Retention Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type:
5.2.1. Patient Recruitment (Recruitment, Pre-screening, Screening, & Enrolment) & Registry Services
5.2.2. Patient Retention Services
Chapter 6. Market Segmentation 2: By Phases Estimates & Trend Analysis
6.1. By Type & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Phases:
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
Chapter 7. Market Segmentation 3: By Disease Estimates & Trend Analysis
7.1. By Type & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease:
7.2.1. Oncology
7.2.2. Infectious Disease
7.2.3. Cardiovascular Disease
7.2.4. CNS/Neurology
7.2.5. Endocrine/Metabolic
7.2.6. Hematological Disorders
7.2.7. Others
Chapter 8. Market Segmentation 4: By Patient Age Group Estimates & Trend Analysis
8.1. By Type & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Patient Age Group:
8.2.1. Pediatric
8.2.2. Geriatrics
8.2.3. Adults
Chapter 9. Market Segmentation 5: By End User Estimates & Trend Analysis
9.1. By Type & Market Share, 2024-2034
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
9.2.1. Hospitals
9.2.2. CROs
9.2.3. Pharma & Biotech Companies
9.2.4. Others
Chapter 10. Patient Recruitment and Retention Services Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
10.1.2. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2021-2034
10.1.3. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Disease, 2021-2034
10.1.4. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By, Patient Age Group, 2021-2034
10.1.5. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By, End User, 2021-2034
10.1.6. North America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By country, 2021-2034
10.1.6.1. U.S.
10.1.6.2. Canada
10.2. Europe
10.2.1. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, 2021-2034
10.2.2. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2021-2034
10.2.3. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Disease, 2021-2034
10.2.4. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group ,2021-2034
10.2.5. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.2.6. Europe Patient Recruitment and Retention Services Market revenue (US$ Million) By country, 2021-2034
10.2.6.1. Germany
10.2.6.2. Poland
10.2.6.3. France
10.2.6.4. Italy
10.2.6.5. Spain
10.2.6.6. UK
10.2.6.7. Rest of Europe
10.3. Asia Pacific
10.3.1. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, 2021-2034
10.3.2. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2021-2034
10.3.3. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Disease, 2021-2034
10.3.4. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2021-2034
10.3.5. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.3.6. Asia Pacific Patient Recruitment and Retention Services Market revenue (US$ Million) By country, 2021-2034
10.3.6.1. China
10.3.6.2. India
10.3.6.3. Japan
10.3.6.4. Australia
10.3.6.5. Rest of Asia Pacific
10.4. Latin America
10.4.1. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, 2021-2034
10.4.2. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2021-2034
10.4.3. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Disease, 2021-2034
10.4.4. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2021-2034
10.4.5. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.4.6. Latin America Patient Recruitment and Retention Services Market revenue (US$ Million) By country, 2021-2034
10.4.6.1. Brazil
10.4.6.2. Rest of Latin America
10.5. Middle East & Africa
10.5.1. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) By Type, (US$ Million)
10.5.2. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Phases, 2021-2034
10.5.3. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Disease, 2021-2034
10.5.4. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By Patient Age Group, 2021-2034
10.5.5. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
10.5.6. Middle East & Africa Patient Recruitment and Retention Services Market revenue (US$ Million) By country, 2021-2034
10.5.6.1. South Africa
10.5.6.2. GCC Countries
10.5.6.3. Rest of MEA
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Acurian
11.2.2. BBK Worldwide
11.2.3. Bright Pharmaceutical Services
11.2.4. Elligo Health Research
11.2.5. CSSi
11.2.6. Clinical Trial Media
11.2.7. Evolution Research Group (ERG)
11.2.8. Integrated Clinical Trial Services (ICTS)
11.2.9. MMG
11.2.10. Veristat
11.2.11. Altasciences Clinical Los Angeles Inc.
11.2.12. Antidote
11.2.13. Clinical Accelerator
11.2.14. Fidelis Research
11.2.15. Ignite Data
11.2.16. Polaris BioPharma Consulting
11.2.17. Clinrol
11.2.18. TrialWire Platform
11.2.19. Other Prominent Players
Patient Recruitment and Retention Services Market By Type
Patient Recruitment and Retention Services Market By Disease
Patient Recruitment and Retention Services Market By Phases
Patient Recruitment and Retention Services Market By Patient Age Group
Patient Recruitment and Retention Services Market By End-User
Patient Recruitment and Retention Services Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
